These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28885000)

  • 1. A Multiplatform Approach for the Discovery of Novel Drug-Induced Kidney Injury Biomarkers.
    Chen L; Smith J; Mikl J; Fryer R; Pack F; Williams BJ; Phillips JA; Papov VV
    Chem Res Toxicol; 2017 Oct; 30(10):1823-1834. PubMed ID: 28885000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspectives on using a multiplex human kidney safety biomarker panel to detect cisplatin-induced tubular toxicity in male and female Cynomolgus monkeys.
    Chen Y; Dale Thurman J; Kinter LB; Bialecki R; Eric McDuffie J
    Toxicol Appl Pharmacol; 2017 Dec; 336():66-74. PubMed ID: 29051111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the MesoScale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model.
    Pavkovic M; Riefke B; Gutberlet K; Raschke M; Ellinger-Ziegelbauer H
    J Pharmacol Toxicol Methods; 2014; 69(2):196-204. PubMed ID: 24333954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of metabolomics biomarkers for early detection of nephrotoxicity.
    Boudonck KJ; Mitchell MW; Német L; Keresztes L; Nyska A; Shinar D; Rosenstock M
    Toxicol Pathol; 2009 Apr; 37(3):280-92. PubMed ID: 19380839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of putative genomic biomarkers of nephrotoxicity in rats.
    Wang EJ; Snyder RD; Fielden MR; Smith RJ; Gu YZ
    Toxicology; 2008 Apr; 246(2-3):91-100. PubMed ID: 18289764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment standards: comparing histopathology, digital image analysis, and stereology for early detection of experimental cisplatin-induced kidney injury in rats.
    Shea K; Stewart S; Rouse R
    Toxicol Pathol; 2014 Aug; 42(6):1004-15. PubMed ID: 24201815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of key metabolites during cisplatin-induced acute kidney injury using an HPLC-TOF/MS-based non-targeted urine and kidney metabolomics approach in rats.
    Qu X; Gao H; Sun J; Tao L; Zhang Y; Zhai J; Song Y; Hu T; Li Z
    Toxicology; 2020 Feb; 431():152366. PubMed ID: 31926187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats.
    Vinken P; Starckx S; Barale-Thomas E; Looszova A; Sonee M; Goeminne N; Versmissen L; Buyens K; Lampo A
    Toxicol Pathol; 2012 Oct; 40(7):1049-62. PubMed ID: 22581811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with Cisplatin.
    Gautier JC; Riefke B; Walter J; Kurth P; Mylecraine L; Guilpin V; Barlow N; Gury T; Hoffman D; Ennulat D; Schuster K; Harpur E; Pettit S
    Toxicol Pathol; 2010 Oct; 38(6):943-56. PubMed ID: 20716785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological qualification of biomarkers of chemical-induced renal toxicity in two strains of male rat.
    Harpur E; Ennulat D; Hoffman D; Betton G; Gautier JC; Riefke B; Bounous D; Schuster K; Beushausen S; Guffroy M; Shaw M; Lock E; Pettit S;
    Toxicol Sci; 2011 Aug; 122(2):235-52. PubMed ID: 21593213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered metabolic profiles and biomarkers associated with astragaloside IV-mediated protection against cisplatin-induced acute kidney injury in rats: An HPLC-TOF/MS-based untargeted metabolomics study.
    Song Y; Hu T; Gao H; Zhai J; Gong J; Zhang Y; Tao L; Sun J; Li Z; Qu X
    Biochem Pharmacol; 2021 Jan; 183():114299. PubMed ID: 33148504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of novel renal biomarkers with a cisplatin model of kidney injury: gender and dosage differences.
    Pinches M; Betts C; Bickerton S; Burdett L; Thomas H; Derbyshire N; Jones HB; Moores M
    Toxicol Pathol; 2012 Apr; 40(3):522-33. PubMed ID: 22491933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells.
    Sohn SJ; Kim SY; Kim HS; Chun YJ; Han SY; Kim SH; Moon A
    Toxicol Lett; 2013 Mar; 217(3):235-42. PubMed ID: 23287709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the relative performance of 12 urinary biomarkers for renal safety across 22 rat sensitivity and specificity studies.
    Vlasakova K; Erdos Z; Troth SP; McNulty K; Chapeau-Campredon V; Mokrzycki N; Muniappa N; Gu YZ; Holder D; Bailey WJ; Sistare FD; Glaab WE
    Toxicol Sci; 2014 Mar; 138(1):3-20. PubMed ID: 24361871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Potential Biomarkers with Dose- and Time-Dependence in Cisplatin-Induced Nephrotoxicity Using Metabolomics Integrated with a Principal Component-Based Area Calculation Strategy.
    Zhang P; Chen J; Wang Y; Huang Y; Tian Y; Zhang Z; Xu F
    Chem Res Toxicol; 2016 May; 29(5):776-83. PubMed ID: 27030963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multiplexed UPLC-MS/MS assay for the simultaneous measurement of urinary safety biomarkers of drug-induced kidney injury and phospholipidosis.
    Tengstrand E; Zhang H; Liu N; Dunn K; Hsieh F
    Toxicol Appl Pharmacol; 2019 Mar; 366():54-63. PubMed ID: 30653977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium-binding protein 1: a sensitive urinary biomarker to detect heavy metal-induced nephrotoxicity.
    Lee EK; Shin YJ; Park EY; Kim ND; Moon A; Kwack SJ; Son JY; Kacew S; Lee BM; Bae ON; Kim HS
    Arch Toxicol; 2017 Apr; 91(4):1635-1648. PubMed ID: 27578022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotoxicity of a novel antineoplastic platinum complex, nedaplatin: a comparative study with cisplatin in rats.
    Uehara T; Watanabe H; Itoh F; Inoue S; Koshida H; Nakamura M; Yamate J; Maruyama T
    Arch Toxicol; 2005 Aug; 79(8):451-60. PubMed ID: 15856183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging increases the susceptibility of cisplatin-induced nephrotoxicity.
    Wen J; Zeng M; Shu Y; Guo D; Sun Y; Guo Z; Wang Y; Liu Z; Zhou H; Zhang W
    Age (Dordr); 2015 Dec; 37(6):112. PubMed ID: 26534724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue expression and correlation of a panel of urinary biomarkers following cisplatin-induced kidney injury.
    Wadey RM; Pinches MG; Jones HB; Riccardi D; Price SA
    Toxicol Pathol; 2014; 42(3):591-602. PubMed ID: 23823703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.